Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics

PHASE3TerminatedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Respiratory InsufficiencyAnoxemia
Interventions
DRUG

Nitrogen gas

Nitrogen gas will be given at 5ppm until Day 28 or extubation

DRUG

inhaled nitric oxide

inhaled nitric oxide will be given at 5 ppm until day 28 or extubation

Trial Locations (16)

10021

New York Presbyterian Hospital, New York

10467

Children's Hospital at Montefiore, The Bronx

21287

The Johns Hopkins Hospital, Baltimore

22908

University of Virginia Pediatric Critical Care, Charlottesville

29425

The Medical University of South Carolina, Charleston

30322

Children's Healthcare of Atlanta at Egleston, Atlanta

32806

Nemours Children's Clinic, Orlando

43205

Children's Hospital, Columbus

44195

The Cleveland Clinic Foundation, Cleveland

44308

Children's Hospital Medical Center of Akron, Akron

60637

University of Chicago, Children's Hospital, Chicago

71103

Louisiana State University Health Sciences Center - Shreveport, Shreveport

80218

The Children's Hospital, Denver

92868

Chrildren's Hospital of Orange County, Orange

94305

Stanford University Medical Center, Stanford

97239

Oregon Health and Science University, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY